tafamidis

Related by string. * * *

Related by context. All words. (Click for frequent words.) 71 SNT MC# 71 lumiliximab 71 Rasagiline 71 OHR/AVR# 69 Dalbavancin 69 TELINTRA 69 proteasome inhibitor 69 Nexavar sorafenib 69 acetonide FA 69 JAK inhibitor 69 sitaxsentan 69 Vandetanib 69 Trofex 69 Phenoptin 69 YONDELIS 69 Aviptadil 68 Removab 68 MAGE A3 ASCI 68 EVIZON TM 68 Mipomersen 68 EndoTAG TM -1 68 axitinib 68 ZOLINZA 68 Azedra 68 MYDICAR ® 68 BAY #-# 68 Ocrelizumab 68 TBC# 68 Arcalyst 68 anidulafungin 68 oxypurinol 68 eltrombopag 68 ATPace TM 68 Panzem R 68 Fx #A 68 Vidaza azacitidine 68 MyVax R 68 efalizumab 67 VAPRISOL 67 oral prodrug 67 HuLuc# 67 huC# DM4 67 Factor VIIa 67 ATL/TV# 67 relapsed leukemia 67 Catena ® 67 Onconase 67 Tocosol Paclitaxel 67 Aflibercept 67 IMA# 67 Adentri 67 Soliris TM eculizumab 67 Gleevec imatinib mesylate 67 investigational humanized monoclonal antibody 67 phase IIb clinical 67 Troxatyl 67 elotuzumab 67 alagebrium 67 rasagiline tablets 67 Aplidin 67 XmAb# 67 severe hypercholesterolemia 67 Vilazodone 67 cannabinor 67 Xanafide 67 octreotide acetate 67 HuMax CD4 67 midstage trials 67 NV1FGF 67 Natalizumab 67 alvimopan 67 atacicept 67 Fibrillex TM 67 radiation sensitizer 67 IL# PE#QQR 67 CEQ# 67 Gleevec Glivec 67 cetuximab Erbitux R 67 RhuDex 67 phase IIa clinical 67 ENMD # 67 AA amyloidosis 67 Amrubicin 67 malignant ascites 67 riociguat 67 histone deacetylase HDAC inhibitor 67 Nuvion 67 CDP# 67 gastrointestinal stromal tumors GIST 67 Neurodex 67 gefitinib Iressa 67 IAP inhibitor 67 beta 1a 67 ELACYT 67 Squalamine 67 idiopathic pulmonary fibrosis IPF 67 trastuzumab DM1 T DM1 67 vascular disrupting agent 67 ruxolitinib 67 pseudobulbar affect PBA 66 Advexin 66 PNP inhibitor 66 Avastin bevacizumab 66 Iluvien ® 66 sorafenib Nexavar 66 Romidepsin 66 PDE4 inhibitor 66 Triolex 66 PROMACTA 66 alvespimycin 66 cediranib 66 Dasatinib 66 targeted radiotherapeutic 66 Huntexil 66 PLK1 SNALP 66 ONTAK 66 Panzem 66 TELCYTA 66 Firazyr 66 PEG SN# 66 ocular formulation 66 INCB# [001] 66 tiapamil 66 postoperative ileus 66 Ceflatonin 66 Zolinza 66 metaglidasen 66 PRT# 66 Nebido 66 VEGF inhibitors 66 FOLOTYN ® 66 Ceflatonin R 66 Targretin 66 Daclizumab 66 RhuDex ® 66 HQK 66 GW# [003] 66 erlotinib Tarceva 66 Iloperidone 66 terlipressin 66 RSR# 66 ACZ# 66 PREOS 66 Cloretazine 66 intranasal formulation 66 PrevOnco 66 Cimzia TM 66 #D#C# 66 Soliris eculizumab 66 vidofludimus 66 Bezielle 66 Pivotal Phase III 66 ILUVIEN ® 66 amrubicin 66 opioid induced bowel dysfunction 66 teduglutide 66 tasocitinib 66 orBec 66 KRN# 66 tezampanel 66 panitumumab Vectibix 66 TG# [003] 66 Zarnestra 66 Traficet EN 66 Alzhemed TM 66 UPLYSO 66 OvaRex ® MAb 66 rThrombin 66 Bortezomib 66 Xinlay 66 ALK inhibitor 66 Octreolin 66 rilonacept 66 Symadex 66 Onrigin 66 urocortin 2 66 Civacir 66 TREANDA 66 vorinostat 66 Sutent sunitinib 66 cancer immunotherapies 66 PF # [002] 66 PLX cells 66 Lixivaptan 66 tanespimycin 66 Arranon 66 Degarelix 66 ProSavin 66 Safinamide 66 selective modulator 66 R#/MEM # 65 anti CD3 antibody 65 pan HDAC inhibitor 65 Dacogen decitabine 65 volociximab 65 subcutaneous formulation 65 Advagraf 65 ixabepilone 65 Exherin TM 65 Nexavar ® 65 dexanabinol 65 Telintra 65 HepeX B 65 Prestara 65 NP2 Enkephalin 65 SUTENT ® 65 mTOR inhibitor 65 ONGLYZA ™ 65 adalimumab Humira 65 tipifarnib 65 Stedivaze 65 mertansine 65 molecular imaging radiopharmaceutical 65 Romiplostim 65 HSP# inhibitor 65 MGd 65 Corlux 65 vemurafenib 65 anticancer therapy 65 humanized anti 65 rhIGF-I/rhIGFBP-3 65 sunitinib malate 65 Tasimelteon 65 PLX# 65 Pimavanserin 65 Temsirolimus 65 cetuximab Erbitux 65 Campath ® 65 T#I [002] 65 etanercept Enbrel 65 Anidulafungin 65 teriflunomide 65 octreotide 65 Cleviprex TM clevidipine 65 methylnaltrexone 65 omacetaxine 65 ALN TTR 65 OXi# 65 schizophrenia CIAS 65 depsipeptide 65 Tyrima 65 CIMZIA TM 65 ARIKACE ™ 65 daclizumab 65 bucindolol 65 Zorbtive TM 65 mapatumumab 65 BRAF inhibitor 65 Gleevec resistant 65 rufinamide 65 phase IIb trial 65 sipuleucel T 65 acyclovir Lauriad R 65 FTY# 65 elacytarabine 65 rNAPc2 65 Phase IIb clinical trials 65 Archexin 65 romiplostim 65 aurora kinase 65 ularitide 65 angiogenesis inhibitor 65 Specifid 65 ATryn ® 65 Cardio Vascu Grow 65 verteporfin 65 supplemental biologics 65 novel histone deacetylase 65 DXL# 65 OncoVEX GM CSF 65 dirucotide 65 Bucindolol 65 calcineurin inhibitor 65 cetuximab Erbitux ® 65 Reverset 65 Crizotinib 65 Ophena TM 65 Granulocyte Colony Stimulating Factor 65 SNT-MC#/idebenone 65 Zemiva TM 65 refractory gout 65 Betaseron ® 65 metastatic malignant 65 synthetic retinoid 65 Vascugel 65 Octreotide 65 oral methylnaltrexone 65 idiopathic thrombocytopenic purpura ITP 65 T Pred 65 odanacatib 65 nonclinical studies 65 Vernakalant 65 Ambrisentan 65 Pradefovir 65 humanised monoclonal antibody 65 KNS # 65 selective androgen receptor modulator 65 tramiprosate 65 Onco TCS 65 Pazopanib 65 lapatinib Tykerb 65 LymphoStat B TM 65 Insegia 65 vascular disrupting agents 65 AQ4N 65 HuMax CD# 65 HCV protease inhibitor 65 systemically administered 65 midstage clinical 65 brivaracetam 65 E2F Decoy 65 methylnaltrexone bromide 65 Sanctura XR 65 Vaprisol 65 ospemifene 65 MyVax 65 Saforis 65 AZILECT ® 65 receptor tyrosine kinase inhibitor 65 Evoltra 65 PI3K/Akt pathway inhibitor 65 XYOTAX TM 65 RAPTIVA 65 liposomal formulation 65 polysaccharide polymer 65 ORENCIA R 65 chronic idiopathic thrombocytopenic purpura 65 octreotide implant 65 Levetiracetam 65 EOquin 65 Sym# 65 Pirfenidone 65 Onalta 65 Vidofludimus 65 Mepact 65 Zenvia ™ 65 virus HCV protease inhibitor 65 silodosin 65 refractory chronic lymphocytic 65 Atrasentan 65 Plicera 65 romidepsin 65 LAF# 65 Tarceva erlotinib 65 Phenserine 65 erlotinib Tarceva ® 65 Proxinium TM 65 Unit Dose Budesonide 65 G#DT 64 OncoVex 64 Rebif ® 64 Golimumab 64 darapladib 64 vandetanib 64 OncoVEX 64 Raptiva ® 64 interferon gamma 1b 64 Actimmune ® 64 ALGRX 64 omacetaxine mepesuccinate 64 leukemia AML 64 PEGylated 64 novel oral anticoagulant 64 Triapine R 64 dextromethorphan quinidine 64 CD# antibody [001] 64 rhThrombin 64 tocilizumab 64 Cimzia ® certolizumab pegol 64 pradefovir 64 alemtuzumab Campath 64 Solazed TM 64 Liprotamase 64 GGF2 64 zileuton 64 Combidex 64 sunitinib Sutent 64 ATL# [001] 64 dacetuzumab 64 Tysabri natalizumab 64 TRO# 64 fosbretabulin 64 cinacalcet HCl 64 MACUGEN 64 AMEVIVE 64 SinuNase TM 64 thrombolytic agent 64 SomatoKine 64 ganetespib 64 Promacta 64 Gleevec imatinib 64 Dendreon Provenge 64 imatinib Gleevec ® 64 IV Busulfex 64 Kepivance 64 Rilutek 64 Sprycel dasatinib 64 anticancer compound 64 zanolimumab 64 mRCC 64 baminercept 64 basiliximab 64 Torisel 64 fostamatinib 64 diabetic gastroparesis 64 Zenapax 64 DPP4 inhibitor 64 BRINAVESS 64 carcinoid syndrome 64 plasma kallikrein inhibitor 64 tremelimumab 64 personalized immunotherapy 64 Gabapentin GR 64 MYLOTARG 64 Zytiga 64 Plenaxis TM 64 Alvesco R 64 Zalbin 64 Fabry Disease 64 ponatinib 64 zafirlukast 64 ZEVALIN ® 64 reslizumab 64 Affinitak 64 Angiocept 64 PEGylated anti 64 sargramostim 64 CA4P 64 ruboxistaurin 64 VA# [002] 64 KIACTA ™ 64 Onalta ™ 64 pharmacological chaperone 64 Evoltra ® 64 Davanat 64 tyrosine kinase inhibitor 64 immunosuppressant drug 64 PSN# [002] 64 cell lymphoma CTCL 64 squalamine 64 MYDICAR 64 lesinurad 64 Icatibant 64 PolyActive ® 64 CCR5 antagonist 64 maribavir 64 Friedreich Ataxia FRDA 64 drug GLPG# 64 Genentech Rituxan 64 ON #.Na 64 Zelapar 64 RoACTEMRA 64 Mirapexin 64 SinuNase ™ 64 Arzerra ofatumumab 64 Cannabinor 64 investigational therapies 64 ganaxolone 64 Cloretazine ® 64 refractory acute myeloid 64 Nuedexta 64 diarrhea predominant irritable 64 CBLC# 64 relapsing remitting multiple sclerosis 64 generation purine nucleoside 64 Herceptin trastuzumab 64 desvenlafaxine 64 mu opioid receptor antagonist 64 herpetic keratitis 64 INTEGRILIN 64 somatostatin analogue 64 Emezine 64 non nucleoside inhibitor 64 ALN TTR# 64 Zingo TM 64 Laquinimod 64 Erbitux cetuximab 64 Canvaxin 64 Epratuzumab 64 Vascular Endothelial Growth 64 MAXY VII 64 Cimzia certolizumab pegol 64 Caprospinol 64 INCB# [003] 64 ALN PCS 64 Junovan TM 64 R sorafenib tablets 64 RSD# 64 lorvotuzumab mertansine 64 ACV1 64 Cethrin 64 Neuvenge 64 Gattex 64 menadione 64 Fludara ® 64 p# MAP kinase inhibitor 64 PSMA ADC 64 favorable pharmacokinetic profile 64 ATL# [002] 64 ImClone Erbitux 64 intravenous acetaminophen 64 recurrent glioblastoma multiforme 64 XL# XL# 64 thalidomide Thalomid 64 Androxal TM 64 OPAXIO 64 Tarceva TM 64 Lu AA# 64 formerly LymphoStat B 64 selective immunoproteasome inhibitor 64 Abbokinase 64 Seliciclib 64 CaPre TM 64 AVASTIN 64 tolevamer 64 IRX 2 64 Dacogen injection 64 EP #R 64 HGS# 64 CINTREDEKIN BESUDOTOX 64 cangrelor 64 NVA# 64 vilazodone 64 esophageal candidiasis 64 MabCampath 64 Raptiva R 64 luteinizing hormone releasing 64 ELND# 64 refractory angina 64 entinostat 64 casopitant 64 PEGylated interferon beta 1a 64 Xenazine ® 64 EGFR inhibitors 64 PDX pralatrexate 64 enzastaurin 64 Luteinizing Hormone Releasing Hormone 64 OMP #R# 64 Rezular 64 Syncria 64 Fampridine 64 CIPN 64 SGS# 64 Glybera 64 lupus nephritis 64 Velac 64 STEDESA 64 Evoltra TM 64 TYZEKA 64 Hedgehog Pathway Inhibitor 64 Virulizin R 64 ranolazine 63 Pruvel 63 mGluR2 NAM 63 Aurora kinase 63 MEK inhibitor 63 GATTEX TM 63 GRN# 63 investigational monoclonal antibody 63 Aclidinium 63 Arimoclomol 63 LymphoStat B 63 Asentar 63 levodopa induced dyskinesia 63 pharmacokinetic PK study 63 Pertuzumab 63 Noxafil 63 MOZOBIL 63 sorafenib tablets 63 SinuNase 63 Cinquil 63 forodesine 63 davunetide 63 Preos 63 VALSTAR 63 Abiraterone acetate 63 HGS ETR2 63 TLR9 agonists 63 Xcellerated T Cells 63 GAMMAGARD 63 Folotyn 63 Pyridorin 63 trastuzumab Herceptin ® 63 diabetic neuropathic pain 63 Aryplase 63 Voraxaze 63 Meets Primary Endpoint 63 Sanvar R 63 post herpetic neuralgia PHN 63 hypereosinophilic syndrome 63 pomalidomide 63 abiraterone acetate 63 CORT # 63 lucinactant 63 AAG geldanamycin analog 63 alpha#beta# integrin 63 ApoB SNALP 63 inhibit metastasis 63 histone deacetylase inhibitor 63 Proquin XR 63 Panzem R NCD 63 thetreatment 63 Aggrastat 63 inhaled liposomal ciprofloxacin 63 GRNVAC1 63 alefacept 63 CYT# potent vascular disrupting 63 Cellcept 63 cilengitide 63 cabozantinib 63 MAb 63 lomitapide 63 Carfilzomib 63 bortezomib Velcade ® 63 ketolide antibiotic 63 Everolimus 63 PPAR gamma agonists 63 Velcade bortezomib 63 #I TM# 63 MyVax ® 63 6R BH4 63 Phase Ib clinical 63 bevacizumab Avastin 63 Orathecin 63 Prosaptide 63 Leukine 63 huN# DM1 63 renal toxicity 63 Keppra XR 63 Bonefos 63 LY# [003] 63 EGS# 63 ONCONASE R 63 RECOTHROM R 63 Amplimexon 63 CGEN # 63 Vicriviroc 63 Arikace 63 trastuzumab Herceptin 63 AZILECT R 63 CIMZIA ™ 63 glucagon receptor 63 immunomodulatory therapy 63 Teriflunomide 63 anti amnesic 63 nucleoside analog 63 INCB# [002] 63 CD# monoclonal antibody 63 GSK# [002] 63 ANAVEX #-# [001] 63 Rituxan rituximab 63 Riquent 63 Curaxin CBLC# 63 Orencia abatacept 63 investigational antiplatelet agent 63 CDK inhibitor 63 Vidaza R 63 Diabetic Macular Edema DME 63 Alocrest 63 AERx iDMS 63 Hycamtin 63 LEP ETU 63 palifermin 63 investigational pan BCR 63 ataluren 63 Pemetrexed 63 Dyloject TM 63 Fibrillex 63 Myfortic 63 inhaled formulation 63 p# inhibitor 63 SU# [003] 63 LEUKINE 63 OMNARIS HFA 63 Cerovive 63 talactoferrin 63 davunetide intranasal AL 63 Xcytrin R 63 Kynapid 63 Relivar 63 ALN HTT 63 pertuzumab 63 Lupuzor 63 PXD# 63 VitiGam 63 humanized antibody 63 Erlotinib 63 tranilast 63 Spiegelmer ® 63 glucokinase activator 63 cytokine refractory 63 ASONEP 63 Interferon beta 1a 63 bicifadine 63 hereditary deficiency 63 imatinib mesylate 63 BNC# 63 APOPTONE 63 interferon beta 1b 63 therapeutic monoclonal antibody 63 ENTEREG ® 63 Talabostat 63 PKC# 63 Kamada AAT 63 JAK1 63 TKM ApoB 63 ocrelizumab 63 hoFH 63 chimeric monoclonal antibody 63 dasatinib Sprycel ® 63 signal transduction inhibitor 63 dexpramipexole 63 PEGylated Fab fragment 63 Rituximab 63 Tavocept 63 Gamunex C 63 Ventavis 63 selective inhibition 63 figitumumab 63 otelixizumab 63 Tezampanel 63 Proleukin 63 Guanilib 63 IMC #B 63 crizotinib 63 phase III isavuconazole 63 BZL# 63 ThGRF 63 Acute Radiation Syndrome ARS 63 Harbor BioSciences 63 Phase Ib study 63 ZACTIMA 63 Cloretazine R 63 PrevOnco ™ 63 INTEGRILIN R 63 TRIOLEX 63 MKC# MKC# PP 63 deferiprone 63 pralatrexate 63 Atiprimod 63 Alfimeprase 63 Sandostatin LAR 63 Phase IIB 63 Cetrorelix 63 Nanobody 63 dimebon 63 IAP inhibitors 63 adecatumumab MT# 63 SARMs 63 torcetrapib atorvastatin 63 AEG# 63 exon skipping 63 Pfizer Sutent 63 pemetrexed Alimta 63 novel peptide 63 rindopepimut 63 visilizumab 63 Alequel 63 Genentech Roche 63 Olaparib 63 personalized cellular immunotherapy 63 PARP inhibitor 63 Ataluren 63 Cethromycin 63 CCR9 antagonist 63 neurotrophic factor 63 Anti VEGF 63 Eraxis 63 solanezumab 63 bardoxolone methyl 63 Phase #b/#a clinical 63 CCX# 63 Gemzar ® 63 EOquin TM 63 TOCOSOL Paclitaxel 63 Bosentan 63 HGS ETR1 mapatumumab 63 antifibrotic 63 THR beta agonist 63 decitabine 63 Omacetaxine 63 diabetic macular edema DME 63 Genz # 63 Silodosin 63 nalbuphine ER 63 Leber Hereditary Optic Neuropathy 63 Viprinex 63 Factor Xa inhibitor 63 incyclinide 63 gabapentin enacarbil 63 ISIS # 63 PROVENGE sipuleucel T 63 Rhucin R 63 Certolizumab pegol 63 goserelin 63 Saxagliptin 63 superficial bladder cancer 63 interferon beta 63 Ventavis ® 63 Personalized Immunotherapy 63 targeting CD# 63 bortezomib Velcade 63 lanreotide 63 ATryn R 63 psoriasis rheumatoid arthritis 63 Alemtuzumab 63 chorea associated 63 clazosentan 63 CD3 monoclonal antibody 63 Jevtana 63 anti TNF alpha 63 Treanda 63 ProMune 63 Marketing Authorisation Application 63 Remicade infliximab 62 glufosfamide 62 aldehyde dehydrogenase ALDH2 deficiency 62 nilotinib 62 EndoTAG TM 62 ABILIFY ® 62 ALN HPN 62 BEMA TM Fentanyl 62 Thiarabine 62 PROCRIT ® 62 Bevacizumab 62 Reolysin 62 trial evaluating PRX# 62 SAR# [004] 62 Phase 2a trial 62 oral ridaforolimus 62 docetaxel Taxotere ® 62 Proellex TM 62 Glufosfamide 62 AzaSite Plus 62 icatibant 62 Ixempra 62 LymphoStat B belimumab 62 Zavesca 62 motexafin gadolinium Injection 62 Muraglitazar 62 vismodegib 62 Egrifta 62 ANG# 62 Solzira 62 evaluating tivozanib 62 kidney urologic 62 preclinically 62 fenretinide 62 Manja Bouman CEO 62 DEB# 62 Desmoteplase 62 iloperidone 62 Enzastaurin 62 Genasense ® 62 Debio 62 Urokinase 62 Cancidas 62 TYSABRI natalizumab 62 alemtuzumab MS 62 immune modulator 62 Leukine ® 62 Fibrin Pad 62 DPX Survivac 62 FK# 62 IMiDs 62 oncolytic virus therapy 62 receptor inhibitor 62 lintuzumab SGN 62 vivo validation 62 adipiplon 62 VEGF receptor inhibitor 62 NS#/#A protease 62 Hydroxyurea 62 MAXY alpha 62 aerosolized KL4 surfactant 62 Myelodysplastic Syndrome MDS 62 Loramyc R 62 BrachySil TM 62 ADVEXIN 62 MAXY G# 62 edifoligide 62 investigational hepatitis C 62 alpha interferon 62 olaparib 62 mitogen activated ERK kinase 62 efaproxiral 62 iniparib 62 StaphVax 62 TORISEL 62 humanized monoclonal antibody 62 OvaRex R 62 delivers fluocinolone acetonide FA 62 inhibitor RG# 62 eniluracil 62 Actemra tocilizumab 62 postoperative ileus POI 62 bevacizumab Avastin ® 62 Ganciclovir 62 standard chemotherapy regimen 62 diabetic kidney 62 CytoFabTM 62 antisense drug 62 LHON 62 Serostim ® 62 C1 INH 62 COPREXA 62 AP# [003] 62 Fingolimod 62 XL# anticancer compounds 62 lenalidomide Revlimid R 62 LibiGel ® 62 long acting muscarinic 62 Virulizin ® 62 PHX# 62 GSK# [001] 62 Cimzia R 62 TOCOSOL Camptothecin 62 Targretin capsules 62 Myocet 62 gastrointestinal disorders characterized 62 gemcitabine Gemzar R 62 Azilect ® 62 drug ISA# 62 Ereska 62 Hepatocellular Carcinoma HCC 62 neurotrophic 62 imatinib mesylate Gleevec 62 Tolvaptan 62 Lenocta 62 Cintredekin Besudotox 62 investigational atypical antipsychotic 62 BRIM2 62 Bicifadine 62 Azacitidine 62 EFAPROXYN 62 TH# [003] 62 HuMax EGFr 62 Mylotarg 62 Interferon alpha 62 CB2 selective receptor agonist 62 Iressa gefitinib 62 SERMs 62 mTOR inhibition 62 cancer neuroendocrine tumor 62 temsirolimus 62 OSI Tarceva 62 ALN VSP 62 echinocandin 62 Aurexis 62 Solazed 62 GVAX 62 Acapodene 62 candesartan cilexetil 62 muraglitazar 62 ORENCIA ® 62 teplizumab 62 Febuxostat 62 MT# MEDI 62 PDE# inhibitors 62 LHRH antagonist 62 Familial Adenomatous Polyposis FAP 62 DOS# 62 orally administered inhibitor 62 AVE# 62 cathepsin K inhibitor 62 Anavex #-# 62 QuadraSphere 62 compound INCB# 62 antifibrinolytic 62 IIa trial 62 TRX1 62 rALLy 62 SUTENT 62 rituximab Rituxan 62 durable remissions 62 PD LID 62 Exelixis compounds 62 antiplatelet agent 62 miconazole Lauriad ® 62 PREOS R 62 PROCHYMAL 62 FoldRx 62 Behcet uveitis 62 thymalfasin 62 Initiates Enrollment 62 EXPAREL TM 62 small molecule tyrosine 62 SPRYCEL ® 62 FDA Approvable Letter 62 Eculizumab 62 budiodarone 62 dasatinib Sprycel 62 talabostat 62 relapsed multiple myeloma 62 TNF Tumor Necrosis Factor 62 antithrombotic 62 Diamyd ® 62 ADVEXIN p# therapy 62 phase IIb study

Back to home page